Title : GDC-0980 (apitolisib) treatment with gemcitabine and/or cisplatin synergistically reduces cholangiocarcinoma cell growth by suppressing the PI3K/Akt/mTOR pathway.

Pub. Date : 2020 Sep 3

PMID : 32819590






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 GDC-0980 (apitolisib) treatment with gemcitabine and/or cisplatin synergistically reduces cholangiocarcinoma cell growth by suppressing the PI3K/Akt/mTOR pathway. Cisplatin AKT serine/threonine kinase 1 Homo sapiens